Navigation Links
Informed Medical Communications Hires New Vice President of Marketing
Date:5/12/2008

EDISON, N.J., May 12 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced the appointment of Scott Stoogenke, as Vice President, Marketing. In this role, Stoogenke will develop and implement marketing strategies for Peer Group, RxDialogue and IMC with the objective to maintain and grow IMC's leadership position in the industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/NYM105LOGO )

Stoogenke joins IMC with over 15 years of life sciences marketing experience, including pharmaceutical brand management and service provider marketing leadership. Most recently, he worked for Covance, Inc. as Director of Corporate Marketing, managing the corporate branding initiative, conferences, e-marketing, and marketing communications. Previously, he worked for PDI, Inc. as Executive Director of Marketing, providing strategic corporate marketing and business development support. His experience also includes a breadth of marketing roles at GlaxoSmithKline and Novo Nordisk, including product management, market research, forecasting, competitive intelligence, managed care marketing, and pipeline development in multiple therapeutic areas.

In addition to his work experience, Stoogenke holds an MBA in marketing/international business from the University of Maryland Smith School of Business, an MA in education/human development from the George Washington University, and a BS in biochemistry/molecular biology from the University of Maryland.

"We are delighted to have someone with Scott's qualifications and enthusiasm join our organization in this capacity," said Steve Budd, CEO of IMC. "Scott's proven expertise in branding and marketing strategy coupled with his experience on both the client and service side of the table provides a perfect fit as we continue to grow our business."

About Informed Medical Communications

Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Leading Through Dialogue, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.


'/>"/>
SOURCE Informed Medical Communications
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
2. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
3. Veran Medical Technologies Secures $4.75M in First Institutional Funding
4. BioMS Medical to present at Rodman and Renshaw Global Healthcare Conference
5. USGI Medical Licenses Incisionless Surgery Technology to Intuitive Surgical
6. BioMS Medical Provides Update On Pipeline Products
7. ATS Medical to Participate at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager
9. Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
10. University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
11. Prescient Medical, Inc. to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... 2017 , ... Ellen Matloff, president and CEO of My ... a 2017 Women of Innovation® finalist. Matloff will be among several women to ... dinner recognizes women accomplished in science, technology, engineering and math (STEM), along with ...
(Date:3/23/2017)... 23, 2017  Agriculture technology company Cool Planet has ... note conversion to commercialize its Cool Terra and Cool ... developing products that are simultaneously profitable as well as ... last 18 months. This latest round of funding was ... The company,s primary product, Cool Terra, ...
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a ... lab samples to full-size tissues, bones, even whole organs to implant in people ... delivers blood deep into the developing tissue. , Current bioengineering techniques, including ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
Breaking Biology Technology:
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today ... to uncover insights to support its reporting, help direct future ... UK,s leading youth charity will be using Brandwatch Analytics social listening ... better understanding of the topics and issues that are a priority ... ...
(Date:3/2/2017)... , March 2, 2017 Summary This ... Perrigo and its partnering interests and activities since 2010. ... Read the ... and Alliance since 2010 report provides an in-depth insight into ... sciences companies. On demand company reports are prepared ...
(Date:3/2/2017)... MELBOURNE, Australia , March 2, 2017 ... Therapeutics Ltd (ASX: CYP), has signed an agreement ... researchers from the Monash Biomedicine Discovery Institute and Department ... , to conduct a further preclinical study to support ... the treatment of asthma.  Asthma is ...
Breaking Biology News(10 mins):